Apolipoproteins as predictors of cardiovascular risk in patients with chronic pancreatitis

• Published in: European review for medical and pharmacological sciences Vol. 27; no. 24; p. 12043
• Main Authors: Kovacheva-Slavova, M, Genov, J, Golemanov, B, Vladimirov, B
• Format: Journal Article
• Language: English
• Published: Italy 01.12.2023
• Subjects: Apolipoprotein A-I; Apolipoproteins; Apolipoproteins B; Atherosclerosis; Cardiovascular Diseases - epidemiology; Cholesterol, HDL; Female; Heart Disease Risk Factors; Humans; Male; Middle Aged; Pancreatitis, Chronic - complications; Risk Factors; Triglycerides
• ISSN: 2284-0729
• DOI: 10.26355/eurrev_202312_34802

Patients with pancreatic diseases are at increased risk of cardiovascular events. Investigating various apolipoprotein forms as important atherogenesis components may improve cardiovascular risk (CVR) prediction. This study aimed to investigate CVR factors in patients with chronic pancreatitis. The study enrolled 70 patients (40 males and 30 females, mean age 55.2 years) with chronic pancreatitis and treated pancreatic exocrine insufficiency. We assessed CVR by apolipoproteins A-I, A-II, B, and C-III, lipid profile; score systems [SCORE risk chart and Framingham Risk Score (FRS)], diabetes mellitus; chronic pancreatitis by M-ANNHEIM classification. Statistics were performed via SPSS v. 22. Low apolipoprotein A-I and high apolipoprotein B levels with increased atherogenic potential were observed in 37 and 26 patients. 45.71% demonstrated a high risk of myocardial infarction with high apolipoprotein B/apolipoprotein A-I ratio. Men are at higher CVR risk. Apolipoproteins A-I and A-II correlated with the cardioprotective high-density lipoprotein (HDL) in contrast to apolipoproteins B and C-III, which correlated strongly with low-density lipoprotein (LDL), total cholesterol (TC), and triglycerides (TG). Increased CVR assessed by FRS correlated with significantly lower apolipoprotein A-I and higher apolipoprotein B and apolipoprotein B/apolipoprotein A-I ratio. With the increase in chronic pancreatitis severity, we observed decreased apolipoproteins and increased apolipoprotein B/apolipoprotein A-I ratio. Apolipoproteins are valuable CVR indicators. Further studies are required to establish a CVR screening panel in this population.